Atractylenolide I (ATL-1) has been shown to be an effective drug in suppressing colorectal tumor progression, primarily by preventing colorectal cancer cell proliferation through glucose metabolism, apoptosis alteration, and stump-like behavior via the AKT/mTOR signaling pathway [150]. This evidence concerns the gene AKT1 and colorectal neoplasm.